Theralase Technologies Inc. V.TLT

Alternate Symbol(s): TLTFF

Healthcare Medical Devices

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.

TSXV:TLT - Post by User

Theralase Technologies Inc. > When the earliest TLT can apply for BreakThrough Designation

<< Previous

Bullboard Posts

Next >>

Comment by winr88on Jan 27, 2022 8:07am

444 Views

Post# 34365803

RE:RE:When the earliest TLT can apply for BreakThrough Designation

Hi 99942Apophis,

As discussed before one can conclude a news release or early release of the quarterly newsletter could be anytime. In my humble amateur opinion, accumulate soon, all the shares your intend to hold for the next leg up in this breakthrough technology.

<< Previous

Bullboard Posts

Next >>

POET increases production capacity to meet AI demand